| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8667941 | Journal of Cardiology | 2018 | 6 Pages |
Abstract
In hypertensive patients with AF, treatment with irbesartan did not have any advantage over amlodipine in the reduction of AF/AT recurrence after catheter ablation or electrical cardioversion.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Hiroshige MD, PhD, FJCC, Koichi MD, PhD, FJCC, Toshiyuki MD, PhD, Atsushi MD, PhD, Junjiro MD, PhD, Takashi MD, PhD, Yasuhiro MD, PhD, Ryusuke MD, PhD, Kenji MD, PhD, Kazuteru MD, PhD, FJCC, Ichiro MD, PhD, Kunihiko MD, PhD, Kenichi MD, PhD, FJCC,